Related Experiment Video
Updated: Jun 1, 2026

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
Published on: December 21, 2014
A therapeutic role for matrix metalloproteinase inhibitors in lung diseases?
R E Vandenbroucke1, E Dejonckheere, C Libert
1Dept for Molecular Biomedical Research, VIB, Ghent University, Ghent (Zwijnaarde), Belgium.
Abstract:
Disruption of the balance between matrix metalloproteinases (MMPs) and their endogenous inhibitors is considered a key event in the development of pulmonary diseases such as chronic obstructive pulmonary disease, asthma, interstitial lung diseases and lung cancer. This imbalance often results in elevated net MMP activity, making MMP inhibition an attractive therapeutic strategy. Although promising results have been obtained, the lack of selective MMP inhibitors, together with limited knowledge regarding the exact functions of a particular MMP, hampers clinical application. This review discusses the involvement of different MMPs in lung disorders and future opportunities and limitations of therapeutic MMP inhibition.
Insights
Imbalances in matrix metalloproteinases (MMPs) contribute to lung diseases like COPD and asthma. MMP inhibitors offer therapeutic potential but face challenges due to lack of selectivity and incomplete understanding of MMP functions.
Area of Science:
- Pulmonary Medicine
- Biochemistry
- Pharmacology
Background:
- Matrix metalloproteinases (MMPs) and their inhibitors maintain extracellular matrix homeostasis.
- An imbalance between MMPs and their inhibitors is implicated in various pulmonary diseases.
- Elevated net MMP activity is a hallmark of lung pathology.
Purpose of the Study:
- To review the role of specific MMPs in lung disorders.
- To explore the therapeutic potential of MMP inhibition for lung diseases.
- To identify challenges and future directions for MMP-targeted therapies.
Main Methods:
- Literature review of studies on MMPs in pulmonary diseases.
- Analysis of existing data on MMP inhibitor efficacy and limitations.
- Discussion of current knowledge gaps in MMP function.
Main Results:
- MMP dysregulation is a common pathway in COPD, asthma, ILDs, and lung cancer.
- MMP inhibition shows promise but lacks specificity.
- Understanding individual MMP roles is crucial for effective treatment.
Conclusions:
- Targeting MMPs is a viable therapeutic strategy for lung diseases.
- Development of selective MMP inhibitors is essential.
- Further research into MMP functions is needed to overcome clinical limitations.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
The Extracellular Matrix
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...